EyePoint Pharmaceuticals Inc. (EYPT) Starts Presentation at B. Riley Conference
EyePoint Pharmaceuticals (NASDAQ: EYPT) is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. The company has two products, YUTIQ and DEXYCU, that were approved by the U.S. Food and Drug Administration in 2018 and have been launched directly in the U.S. during the first quarter of 2019. For more information, visit the company's website at www.eyepointpharma.com About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services…







